| 2024-04-19 | 178426.26 | 177257.62 | 177257.62 | 回购注销12,599,946股 |
| 2023-06-27 | 179686.25 | 178529.52 | 178529.52 | 99,916,513股增发A股法人配售股份上市 |
| 2022-12-28 | 179686.25 | 168459.47 | 168459.47 | 835,885,761股增发A股法人配售股份上市 |
| 2022-06-30 | 179686.25 | 84890.49 | 84890.49 | 424,231股激励期权行权 |
| 2022-06-06 | 179643.83 | 83588.07 | 83588.07 | 216,343股激励期权行权 |
| 2022-05-05 | 179622.20 | 84827.43 | 84827.43 | 10送4 |
| 2022-04-29 | 128301.57 | 60602.27 | 60602.27 | 300455股激励期权行权 |
| 2021-12-31 | 128271.52 | 60572.23 | 60572.23 | 3,578,418股激励期权行权 |
| 2021-06-30 | 127913.68 | 60390.05 | 60390.05 | 1,733,507股激励期权行权 |
| 2019-07-03 | 127740.33 | 60896.58 | 60896.58 | 668,430,196股增发股份上市 |
| 2019-07-02 | 127740.33 | 60896.58 | 60896.58 | 非公开增发A股668,430,196股;白药控股持有的本公司432,426,597股股份将于2019年7月2日注销。 |
| 2014-05-28 | 104139.97 | 104136.53 | 104136.53 | 10送5 |
| 2012-01-10 | 69426.65 | 69424.54 | 69424.54 | 6500万股增发A股法人配售股份上市 |
| 2010-07-16 | 69426.65 | 62924.54 | 62924.54 | 10转增3 |
| 2009-06-11 | 53405.11 | 48399.17 | 48399.17 | 本次限售股份实际可上市流通数239,166,027股 |
| 2008-12-25 | 53405.11 | 24483.65 | 24483.65 | 非公开增发A股5000万股 |
| 2008-06-16 | 48405.11 | 24483.65 | 24483.65 | 本次有限售条件的流通股上市数量为24,202,557股 |
| 2007-05-29 | 48405.11 | 22062.93 | 22062.93 | 3396.9342万股限售流通股份上市 |
| 2006-07-13 | 48405.11 | 18664.22 | 18664.22 | 10送5 |
| 2006-05-29 | 32270.08 | 12442.82 | 12442.82 | 股权分置方案实施:公司向流通股股东每10股转增3.5815股 |